Evaluation of the Relationship Between Favipiravir Use and Telogen Effluvium in COVID-19 Patients
May 2023
in “
Journal of contemporary medicine
”
Studysummary This study observed that patients who received Favipiravir treatment after having COVID-19 had lower positive pull test scores for telogen effluvium hair loss compared to those who did not, suggesting that Favipiravir may not influence the development of telogen effluvium.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on dergipark.org.tr →